Proathlete Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$37.9K Buy
90
+75
+500% +$29.9K 0.01% 167
2026
Q2
$5.47K Hold
15
– – ﹤0.01% 168
2026
Q1
$5.28K Hold
15
– – ﹤0.01% 171
2025
Q4
$4.91K Buy
+15
New +$4.76K ﹤0.01% 183
2025
Q3
– Sell
-4
Closed -$1.12K – 235
2025
Q2
$1.12K Buy
+4
New +$1.13K ﹤0.01% 224

Other funds holding AMGN

Proathlete Wealth Management's AMGN Position: Q3 2026 in Review

Proathlete Wealth Management increased its Amgen (AMGN) stake by 500% in Q3 2026, buying an estimated $29.9K and bringing the position to 90 shares worth $37.9K. The position accounts for 0.01% of the portfolio, ranked #167.

Proathlete Wealth Management first reported a position in AMGN in Q2 2025 and has held it in 5 quarters since. 3,275 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Proathlete Wealth Management held 90 shares of Amgen worth $37.9K as of Q3 2026.
  • Proathlete Wealth Management bought 75 Amgen shares in Q3 2026, an estimated $29.9K.
  • Amgen made up 0.01% of Proathlete Wealth Management's portfolio in Q3 2026, its #167 holding.
  • Proathlete Wealth Management first reported a position in Amgen in Q2 2025 and has held it in 5 quarters since.
  • 3,275 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Proathlete Wealth Management's 13F filing for Q3 2026, filed 15 Oct 2026.